↓ Skip to main content

SRC-RAC1 signaling drives drug resistance to BRAF inhibition in de-differentiated cutaneous melanomas

Overview of attention for article published in npj Precision Oncology, October 2022
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (53rd percentile)

Mentioned by

twitter
6 X users

Readers on

mendeley
14 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
SRC-RAC1 signaling drives drug resistance to BRAF inhibition in de-differentiated cutaneous melanomas
Published in
npj Precision Oncology, October 2022
DOI 10.1038/s41698-022-00310-7
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 14 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 14 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Researcher 3 21%
Student > Master 2 14%
Student > Doctoral Student 1 7%
Professor 1 7%
Student > Ph. D. Student 1 7%
Other 0 0%
Unknown 6 43%
Readers by discipline
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 6 43%
Nursing and Health Professions 1 7%
Social Sciences 1 7%
Neuroscience 1 7%
Unknown 5 36%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 October 2022.
All research outputs
#14,434,286
of 23,575,346 outputs
Outputs from npj Precision Oncology
#279
of 358 outputs
Outputs of similar age
#198,537
of 446,419 outputs
Outputs of similar age from npj Precision Oncology
#23
of 27 outputs
Altmetric has tracked 23,575,346 research outputs across all sources so far. This one is in the 37th percentile – i.e., 37% of other outputs scored the same or lower than it.
So far Altmetric has tracked 358 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 19.4. This one is in the 20th percentile – i.e., 20% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 446,419 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 53% of its contemporaries.
We're also able to compare this research output to 27 others from the same source and published within six weeks on either side of this one. This one is in the 14th percentile – i.e., 14% of its contemporaries scored the same or lower than it.